|
|
|
Volumn 55, Issue 9 SUPPL. B, 1994, Pages 161-165
|
|
The pharmacoeconomics of clozapine: A review
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOZAPINE;
LEVODOPA;
RISPERIDONE;
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG INDICATION;
HEALTH ECONOMICS;
HUMAN;
MANIC DEPRESSIVE PSYCHOSIS;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
COST-BENEFIT ANALYSIS;
DRUG COSTS;
HOSPITALIZATION;
HUMAN;
SCHIZOPHRENIA;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TREATMENT OUTCOME;
|
|
EID: 0027985385
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (61)
|
|
References (0)
|
